Morning Briefing
Summaries of health policy coverage from major news organizations
Some Scientists Question Results Of Recent HIV Vaccine Clinical Trial
Weeks after clinical trial results showed an experimental HIV vaccine offered some potential protection against the virus, "a second analysis of the $105 million study, not disclosed publicly, suggests the results may have been a fluke," the Wall Street Journal reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
